State Street Corps Strategic Acquisition of ADMA Biologics Shares

ADMA Stock  USD 20.12  0.32  1.57%   
About 59% of ADMA Biologics' investor base is looking to short. The analysis of the overall investor sentiment regarding ADMA Biologics suggests that many traders are alarmed. The current market sentiment, together with ADMA Biologics' historical and current headlines, can help investors time the market. In addition, many technical investors use ADMA Biologics stock news signals to limit their universe of possible portfolio assets.
Overview of the Recent Transaction On September 30, 2024, State Street Corp significantly increased its stake in ADMA Biologics Inc, a key player in the biophar

Read at gurufocus.com
Gurufocus Stories at Macroaxis
  

ADMA Biologics Current Investor Sentiment

Comfort Level 41

 Impartial

 
Panic
 
Confidence
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use ADMA Biologics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward ADMA Biologics.

ADMA Biologics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards ADMA Biologics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

ADMA Biologics Historical Investor Sentiment

Investor biases related to ADMA Biologics' public news can be used to forecast risks associated with an investment in ADMA. The trend in average sentiment can be used to explain how an investor holding ADMA can time the market purely based on public headlines and social activities around ADMA Biologics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ADMA Biologics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ADMA Biologics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average ADMA Biologics news discussions. The higher the estimate score, the more favorable the investor's outlook on ADMA Biologics.

ADMA Biologics Fundamental Analysis

We analyze ADMA Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ADMA Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ADMA Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Liabilities

Current Liabilities Comparative Analysis

ADMA Biologics is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

ADMA Biologics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ADMA Biologics stock to make a market-neutral strategy. Peer analysis of ADMA Biologics could also be used in its relative valuation, which is a method of valuing ADMA Biologics by comparing valuation metrics with similar companies.

Peers

ADMA Biologics Related Equities

SANASana Biotechnology   24.40   
0%
100.0%
ETNB89bio   17.27   
0%
70.0%
ANEBAnebulo Pharmaceuticals   10.89   
0%
44.0%
ACLXArcellx   3.47   
0%
14.0%
FATEFate Therapeutics   2.46   
0%
10.0%
PLXProtalix Biotherapeutics   2.38   
0%
9.0%
STOKStoke Therapeutics   2.24   
0%
9.0%
MDGLMadrigal Pharmaceuticals   0.70   
0%
2.0%
CDTXCidara Therapeutics   0.91   
3.0%
0%
ANTXAN2 Therapeutics   1.68   
6.0%
0%
BCRXBioCryst Pharmaceuticals   2.52   
10.0%
0%
INMBINmune Bio   2.86   
11.0%
0%
PLRXPliant Therapeutics   2.92   
11.0%
0%
AKBAAkebia Ther   3.77   
15.0%
0%
TNXPTonix Pharmaceuticals   5.25   
21.0%
0%
IBIOIBio, Common   6.10   
25.0%
0%
MCRBSeres Therapeutics   6.55   
26.0%
0%
XFORX4 Pharmaceuticals   7.19   
29.0%
0%
VXRTVaxart   9.80   
40.0%
0%

Complementary Tools for ADMA Stock analysis

When running ADMA Biologics' price analysis, check to measure ADMA Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ADMA Biologics is operating at the current time. Most of ADMA Biologics' value examination focuses on studying past and present price action to predict the probability of ADMA Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ADMA Biologics' price. Additionally, you may evaluate how the addition of ADMA Biologics to your portfolios can decrease your overall portfolio volatility.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency